Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
CALL
Tanger
SKT
$4.42B
| $5.93M | ﹤0.01% |
416,800
+171,700
| +70% | +$2.85M |
|
3402
CALL
California Resources
CRC
$4.73B
| $5.92M | ﹤0.01% |
153,900
-1,000
| -0.6% | -$42.9K |
|
3403
CALL
Camping World
CWH
$662M
| $5.92M | ﹤0.01% |
274,100
-79,500
| -22% | -$2.1M |
|
3404
CALL
Tapestry
TPR
$25.7B
| $5.92M | ﹤0.01% |
193,900
-30,400
| -14% | -$995K |
|
3405
Keurig Dr Pepper
KDP
$42.8B
| $5.92M | ﹤0.01% |
167,202
-1,000,984
| -86% | -$36.3M |
|
3406
Vanguard Global ex-US Real Estate ETF
VNQI
$3.51B
| $5.91M | ﹤0.01% |
133,507
+79,523
| +147% | +$3.8M |
|
|
SPYM
3407
CALL
State Street SPDR Portfolio S&P 500 ETF
SPYM
$169B
| $5.91M | ﹤0.01% |
133,200
+63,100
| +90% | +$3.04M |
|
3408
Cerence
CRNC
$407M
| $5.9M | ﹤0.01% |
233,828
+191,007
| +446% | +$5.71M |
|
3409
Credicorp
BAP
$30.7B
| $5.9M | ﹤0.01% |
49,168
-5,776
| -11% | -$794K |
|
3410
Hudbay
HBM
$11.9B
| $5.89M | ﹤0.01% |
1,444,457
+558,148
| +63% | +$3.33M |
|
3411
CALL
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$629M
| $5.89M | ﹤0.01% |
43,710
+2,310
| +6% | +$393K |
|
3412
AEON Biopharma
AEON
$13.4M
| $5.89M | ﹤0.01% |
8,346
-6,927
| -45% | -$4.89M |
|
|
SWCH
3413
CALL
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $5.88M | ﹤0.01% |
175,600
-82,000
| -32% | -$2.65M |
|
|
TETC
3414
DELISTED
Tech and Energy Transition Corporation Class A Common Stock
TETC
| $5.88M | ﹤0.01% |
601,355
-1,099,502
| -65% | -$10.8M |
|
3415
CALL
Vermilion Energy
VET
$1.73B
| $5.88M | ﹤0.01% |
308,500
+136,800
| +80% | +$2.85M |
|
3416
Varex Imaging
VREX
$779M
| $5.88M | ﹤0.01% |
274,666
-36,304
| -12% | -$772K |
|
3417
PUT
New Oriental
EDU
$8.36B
| $5.87M | ﹤0.01% |
288,370
+95,460
| +49% | +$1.31M |
|
|
GSQD
3418
DELISTED
G Squared Ascend I Inc.
GSQD
| $5.86M | ﹤0.01% |
597,684
+1,596
| +0.3% | +$15.7K |
|
|
HLAH
3419
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Class A Common Stock
HLAH
| $5.86M | ﹤0.01% |
596,739
-850,303
| -59% | -$8.34M |
|
3420
PUT
PVH
PVH
$3.8B
| $5.86M | ﹤0.01% |
102,900
-194,900
| -65% | -$13.5M |
|
3421
PUT
JPMorgan Equity Premium Income ETF
JEPI
$46.3B
| $5.85M | ﹤0.01% |
105,500
+33,100
| +46% | +$1.92M |
|
|
NRAC
3422
DELISTED
Northern Revival Acquisition Corporation Class A Ordinary Share
NRAC
| $5.85M | ﹤0.01% |
595,468
+1,351
| +0.2% | +$13.3K |
|
3423
CALL
FTI Consulting
FCN
$4.19B
| $5.84M | ﹤0.01% |
32,300
+20,200
| +167% | +$3.33M |
|
|
PDCE
3424
CALL
DELISTED
PDC Energy, Inc.
PDCE
| $5.84M | ﹤0.01% |
94,800
+1,100
| +1% | +$79.7K |
|
3425
PUT
Ollie's Bargain Outlet
OLLI
$4.62B
| $5.83M | ﹤0.01% |
99,300
+12,100
| +14% | +$612K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.